Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,854 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A phase II trial of nivolumab followed by ipilimumab and nivolumab in advanced non-clear-cell renal cell carcinoma.
Conduit C, Davis ID, Goh JC, Kichenadasse G, Gurney H, Harris CA, Pook D, Krieger L, Parnis F, Underhill C, Adams D, Roncolato F, Joshua A, Ferguson T, Prithviraj P, Morris M, Harrison M, Begbie S, Hovey E, George M, Liow EC, Link EK, McJannett M, Gedye C; Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP); UNISoN Investigators. Conduit C, et al. Among authors: harrison m. BJU Int. 2024 Feb;133 Suppl 3:57-67. doi: 10.1111/bju.16190. Epub 2023 Nov 20. BJU Int. 2024. PMID: 37986556 Clinical Trial.
Patterns of Presentation and Treatment Outcomes of Non-clear-cell Renal Cell Carcinoma and Sarcomatoid Renal Cell Carcinoma Patients in 2 Tertiary Referral Centers in Sydney, Australia.
Naher S, Padinharakam S, Balakrishnar B, Chua W, Descallar J, Adams D, de Souza P, Harrison M, Lim S. Naher S, et al. Among authors: harrison m. Clin Genitourin Cancer. 2019 Jun;17(3):e565-e569. doi: 10.1016/j.clgc.2019.02.006. Epub 2019 Feb 27. Clin Genitourin Cancer. 2019. PMID: 30935815
REZOLVE (ANZGOG-1101): A phase 2 trial of intraperitoneal bevacizumab to treat symptomatic ascites in patients with chemotherapy-resistant, epithelial ovarian cancer.
Sjoquist KM, Espinoza D, Mileshkin L, Ananda S, Shannon C, Yip S, Goh J, Bowtell D, Harrison M, Friedlander ML. Sjoquist KM, et al. Among authors: harrison m. Gynecol Oncol. 2021 May;161(2):374-381. doi: 10.1016/j.ygyno.2021.02.002. Epub 2021 Feb 23. Gynecol Oncol. 2021. PMID: 33637349 Free article. Clinical Trial.
Physical activity behaviors in cancer survivors treated with neurotoxic chemotherapy.
Mizrahi D, Goldstein D, Trinh T, Li T, Timmins HC, Harrison M, Marx GM, Hovey EJ, Lewis CR, Friedlander M, Park SB. Mizrahi D, et al. Among authors: harrison m. Asia Pac J Clin Oncol. 2023 Feb;19(1):243-249. doi: 10.1111/ajco.13834. Epub 2022 Jul 25. Asia Pac J Clin Oncol. 2023. PMID: 35879821 Free PMC article.
Biomarkers for tyrosine kinase inhibitors in renal cell cancer.
Coupe N, Harrison M, Chua W, de Souza P. Coupe N, et al. Among authors: harrison m. Transl Androl Urol. 2012 Dec;1(4):216-22. doi: 10.3978/j.issn.2223-4683.2012.10.01. Transl Androl Urol. 2012. PMID: 26816714 Free PMC article. Review. No abstract available.
Mucinous ovarian carcinoma: A survey of practice in Australia and New Zealand.
Rajadevan N, Flinkier A, Saunders H, Lee YC, Scott C, Khaw P, Allan P, Davies C, Andrews J, Wilson M, Lombard JM, Harrison M, Nesfield H, DeFazio A, Meniawy T, Gorringe KL. Rajadevan N, et al. Among authors: harrison m. Aust N Z J Obstet Gynaecol. 2024 Feb 1. doi: 10.1111/ajo.13792. Online ahead of print. Aust N Z J Obstet Gynaecol. 2024. PMID: 38299485
Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.
Gao B, Lu Y, Nieuweboer AJM, Xu H, Beesley J, Boere I, de Graan AM, de Bruijn P, Gurney H, J Kennedy C, Chiew YE, Johnatty SE, Beale P, Harrison M, Luccarini C, Conroy D, Mathijssen RHJ, R Harnett P, Balleine RL, Chenevix-Trench G, Macgregor S, de Fazio A. Gao B, et al. Among authors: harrison m. Sci Rep. 2018 Jan 24;8(1):1508. doi: 10.1038/s41598-018-19590-w. Sci Rep. 2018. PMID: 29367611 Free PMC article.
3,854 results